AKT1 and Hyperglycemia: For instance, persistent hyperglycemia and insulin resistance disrupt bone matrix metabolism and osteoblast differentiation via interfering with the PI3K/Akt signaling pathway and D-chiro-inositol (DCI)-related metabolic processes, thereby impairing bone matrix integrity and weakening metabolic regulatory capacity (23).